NCT05083481
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05083481
Title A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
Providence Medical Foundation Fullerton California 92835 United States Details
California Research Institute Los Angeles California 90027 United States Details
USC/Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Florida Cancer Specialist & Research Institute Sarasota Sarasota Florida 34232 United States Details
University of Chicago Chicago Illinois 60637 United States Details
University of Kentucky Medical Center MCC-CRO Lexington Kentucky 40536 United States Details
Nebraska Methodist Hospital Omaha Nebraska 68130 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
Mary Crowley Research Center Dallas Texas 75230 United States Details
University of Wisconsin Clinical Science Center Madison Wisconsin 53792 United States Details
Sun Yat-Sen University Cancer Center Guangzhou Guangdong China Details
Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU) Hangzhou Zhejiang China Details
Beijing Cancer Hospital Beijing China Details
Shanghai East Hospital Shanghai China Details
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China Details
FR33007 Besançon France Details
Site FR33002 Bordeaux France Details
FR33008 Paris France Details
FR33005 Saint-Herblain France Details
FR33009 Toulouse France Details
National Cancer Center Hospital Chuo-ku Tokyo Japan Details
Cancer Institute Hospital Of JFCR Koto-ku Tokyo Japan Details
Puerto Rico Medical Center Río Piedras Puerto Rico Details
Site ES34005 A Coruña, Barcelona Spain Details
Site ES34002 Madrid Spain Details
ES34008 Málaga Spain Details
Site ES34007 Málaga Spain Details
Site ES34006 Pozuelo de Alarcón Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field